News | Cardiovascular Business | March 07, 2022

AdvaMed Mourns the Passing of Wendy Siminski

AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:

“Wendy embodied the very best of AdvaMed, and her optimistic, ambitious spirit inspired everyone around her to rise to meet her unwavering standard of excellence. You’d never catch Wendy without a big smile and a list of ideas to leave a project better than she found it. The MedTech Conference is successful today because of Wendy’s hard work and determination. 

“Wendy was confident, collaborative, and courageous until the very end. She was a bright light on our team, and that light will continue to guide us and give us warmth in the months and years to come. At AdvaMed, the patients we serve motivate us; Wendy is no exception, and, in fact, she’s the perfect example. Her fight with cancer drives us all to fight harder for medtech innovation, so perhaps future generations – even Wendy’s own daughters – can conquer this terrible disease once and for all.

“We will miss Wendy dearly, and we’re sending comfort, peace, and strength to her family during this difficult time.”

As Senior Vice President, Wendy served as a lead planner for The MedTech Conference, AdvaMed’s annual flagship conference for the medical technology industry, and all other AdvaMed events and conferences. Her efforts grew the Conference’s programming footprint – at the 2020 conference alone, participants could access more than 150 sessions featuring more than 500 speakers – as well as the conference’s standards for inclusion and diversity – at the 2020 conference, women and minorities were represented in 95% of session panels. Prior to her time at AdvaMed, Wendy led teams at BIO, the AUVSI Foundation, O’Keefe Communications, National Trade Productions, and the Cellular Telecommunications and Internet Association.

Wendy was also a fierce patient advocate for the medtech industry; you can read her profile in AdvaMed’s Story of MedTech series here.

She is survived by her two daughters, Kira and Ashley.

In lieu of flowers, Wendy’s family requests that donations be made in Wendy’s honor to METAvivor. One-hundred percent of all donations made to METAvivor go directly to fund grant awards for metastatic breast cancer research.

For more information: www.advamed.org


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now